Index of reports
> Cases with Hypertension (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Zestoretic (Lisinopril / Hydrochlorothiazide) where reactions include hypertension. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Zestoretic side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-15
Patient: female, weighing 89.4 kg (196.7 pounds)
Reactions: Dysarthria, Polymedication, Mental Status Changes, Headache, Hypertension, Asthenia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lexapro
Administration route: Oral
Indication: Post-Traumatic Stress Disorder
Ambien
Administration route: Oral
Indication: Insomnia
Lyrica
Administration route: Oral
Indication: Fibromyalgia
Clonazepam
Administration route: Oral
Indication: Bipolar Disorder
Ibuprofen
Administration route: Oral
Indication: Fibromyalgia
Placebo
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Lexapro
Administration route: Oral
Indication: Bipolar Disorder
Robaxin
Indication: Fibromyalgia
Zestoretic
Dosage: 20/12.5 daily
Administration route: Oral
Indication: Hypertension
Start date: 2008-12-04
Desvenlafaxine Succinate Monohydrate
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Placebo
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Loratadine
Administration route: Oral
Indication: Seasonal Allergy
Vicodin
Dosage: 5/500 as needed
Administration route: Oral
Indication: Fibromyalgia
Vivelle
Indication: Hormone Replacement Therapy
Desvenlafaxine Succinate Monohydrate
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Abilify
Administration route: Oral
Indication: Bipolar I Disorder
Fluticasone
Indication: Seasonal Allergy
Possible Zestoretic side effects in female
Reported by a physician from United States on 2012-03-13
Patient: female, weighing 89.4 kg (196.7 pounds)
Reactions: Dysarthria, Polymedication, Mental Status Changes, Condition Aggravated, Hypertension, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abilify
Dosage: 15 mg, 2x/day
Administration route: Oral
Indication: Bipolar I Disorder
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Lexapro
Dosage: 20 mg, 1x/day
Administration route: Oral
Indication: Post-Traumatic Stress Disorder
Fluticasone
Dosage: 2 sprays daily route: in
Indication: Seasonal Allergy
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Lyrica
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Fibromyalgia
Robaxin
Dosage: 750 mg, 3x/day
Administration route: Oral
Indication: Fibromyalgia
Clonazepam
Dosage: 1 mg, 2x/day
Administration route: Oral
Indication: Bipolar Disorder
Vicodin
Dosage: 5/500 prn
Administration route: Oral
Indication: Fibromyalgia
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Loratadine
Dosage: 10 mg, 1x/day
Administration route: Oral
Indication: Seasonal Allergy
Robaxin
Dosage: unknown
Lexapro
Indication: Bipolar Disorder
Vivelle
Dosage: 0.1 mg, unk
Indication: Hormone Replacement Therapy
Ibuprofen
Dosage: 800 mg, 3x/day
Administration route: Oral
Indication: Fibromyalgia
Ambien
Dosage: 10 mg, 1x/day
Administration route: Oral
Indication: Insomnia
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Zestoretic
Dosage: 20/12.5 daily
Administration route: Oral
Indication: Hypertension
Start date: 2008-12-04
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Possible Zestoretic side effects in 72 year old female
Reported by a consumer/non-health professional from United States on 2012-02-13
Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)
Reactions: Urethral Cancer, Respiratory Disorder, Tinnitus, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiac Disorder, Cardiomegaly, Balance Disorder, Blindness Unilateral, Tympanic Membrane Perforation, Bladder Cancer, Nasal Congestion, Wound Infection, Ulcer, Accident, Ischaemia, Renal Colic, Pain, Speech Disorder, Eye Haemorrhage, Overdose, Coronary Artery Occlusion, Dysgraphia, Heart Rate Irregular, Transient Ischaemic Attack, Kidney Infection, Myocardial Infarction, Eye Disorder, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Eye Pain, Arrhythmia, Renal Failure, Ureteric Cancer, Diarrhoea, Carditis, Bladder Disorder, Hypertension
Drug(s) suspected as cause:
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2005-12-01
End date: 2008-05-01
Zestoretic
Dosage: 10/12.5 mg
Administration route: Oral
Indication: Hypertension
Start date: 2002-01-01
End date: 2005-12-01
Diovan
Start date: 2009-09-01
End date: 2011-10-01
Zestoretic
Administration route: Oral
Avastin
Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Vitamin TAB; Aspirin; Bactrim; Sulfadiazine
Possible Zestoretic side effects in 72 year old female
Reported by a consumer/non-health professional from United States on 2012-01-17
Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)
Reactions: Respiratory Disorder, Urethral Cancer, Tinnitus, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiac Disorder, Cardiomegaly, Balance Disorder, Blindness Unilateral, Tympanic Membrane Perforation, Bladder Cancer, Wound Infection, Nasal Congestion, Ulcer, Accident, Ischaemia, Renal Colic, Pain, Speech Disorder, Eye Haemorrhage, Overdose, Coronary Artery Occlusion, Heart Rate Irregular, Eye Disorder, Myocardial Infarction, Kidney Infection, Transient Ischaemic Attack, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Arrhythmia, Eye Pain, Ureteric Cancer, Renal Failure, Diarrhoea, Carditis, Bladder Disorder, Hypertension
Drug(s) suspected as cause:
Tenormin
Administration route: Oral
Indication: Hypertension
Start date: 2005-12-01
End date: 2008-05-01
Zestoretic
Dosage: 10/12.5 mg
Administration route: Oral
Indication: Hypertension
Start date: 2002-01-01
End date: 2005-12-01
Diovan
Start date: 2009-09-01
End date: 2011-10-01
Avastin
Other drugs received by patient: Sulfadiazine; Bactrim; Aspirin; Vitamin TAB; Atenolol / Chlorthiadone(mylan)
Possible Zestoretic side effects in 72 year old female
Reported by a individual with unspecified qualification from United States on 2011-12-30
Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)
Reactions: Tinnitus, Respiratory Disorder, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiomegaly, Cardiac Disorder, Balance Disorder, Tympanic Membrane Perforation, Bladder Cancer, Nasal Congestion, Ulcer, Accident, Ischaemia, Renal Colic, Pain, Eye Haemorrhage, Speech Disorder, Overdose, Coronary Artery Occlusion, Heart Rate Irregular, Eye Disorder, Transient Ischaemic Attack, Kidney Infection, Myocardial Infarction, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Arrhythmia, Eye Pain, Ureteric Cancer, Renal Failure, Diarrhoea, Bladder Disorder, Blindness, Hypertension, Infection
Drug(s) suspected as cause:
Avastin
Tenormin
Administration route: Oral
Indication: Hypertension
Zestoretic
Dosage: 10/12.5 mg
Administration route: Oral
Indication: Hypertension
Start date: 2002-01-01
End date: 2005-11-23
Diovan
Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Aspirin; Bactrim; Vitamin TAB; Sulfadiazine
Possible Zestoretic side effects in 72 year old female
Reported by a consumer/non-health professional from United States on 2011-12-23
Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)
Reactions: Respiratory Disorder, Tinnitus, Ear Haemorrhage, Anaphylactic Reaction, Deafness, Headache, Cardiac Disorder, Balance Disorder, Tympanic Membrane Perforation, Bladder Cancer, Ulcer, Accident, Dysphonia, Renal Colic, Pain, Eye Haemorrhage, Overdose, Heart Rate Irregular, Myocardial Infarction, Eye Disorder, Transient Ischaemic Attack, Kidney Infection, Decreased Appetite, Renal Disorder, Cerebral Atrophy, Purpura, Cerebrovascular Accident, Eye Pain, Renal Failure, Ureteric Cancer, Diarrhoea, Bladder Disorder, Hypertension, Infection
Drug(s) suspected as cause:
Avastin
Tenormin
Administration route: Oral
Indication: Hypertension
Diovan
Zestoretic
Dosage: 10/12.5 mg
Administration route: Oral
Indication: Hypertension
Start date: 2002-01-01
End date: 2005-11-23
Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Vitamin TAB; Sulfadiazine; Bactrim; Aspirin
Possible Zestoretic side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-23
Patient: female, weighing 89.4 kg (196.7 pounds)
Reactions: Dysarthria, Polymedication, Mental Status Changes, Headache, Hypertension, Asthenia, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Desvenlafaxine Succinate Monohydrate
Administration route: Oral
Start date: 2008-09-09
End date: 2008-11-22
Lexapro
Indication: Ill-Defined Disorder
Fluticasone Furoate
Indication: Ill-Defined Disorder
Loratadine
Indication: Ill-Defined Disorder
Vicodin
Dosage: 5/500 as needed
Indication: Ill-Defined Disorder
Ambien
Administration route: Oral
Indication: Ill-Defined Disorder
Lyrica
Indication: Ill-Defined Disorder
Placebo
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Abilify
Indication: Ill-Defined Disorder
Vivelle
Indication: Ill-Defined Disorder
Zestoretic
Dosage: 20/12.5 daily
Indication: Ill-Defined Disorder
Desvenlafaxine Succinate Monohydrate
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-11-29
End date: 2008-12-24
Robaxin
Indication: Ill-Defined Disorder
Ibuprofen
Indication: Ill-Defined Disorder
Placebo
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Clonazepam
Indication: Ill-Defined Disorder
Possible Zestoretic side effects in female
Reported by a physician from United States on 2011-12-20
Patient: female, weighing 89.4 kg (196.7 pounds)
Reactions: Dysarthria, Polymedication, Mental Status Changes, Condition Aggravated, Hypertension, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Ibuprofen
Dosage: 800 mg, 3x/day
Robaxin
Dosage: unknown
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Clonazepam
Dosage: 1 mg, 2x/day
Lexapro
Dosage: 20 mg, 1x/day
Vicodin
Dosage: 5/500 prn
Ambien
Dosage: 10 mg, 1x/day
Administration route: Oral
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Zestoretic
Dosage: 20/12.5 daily
Lyrica
Dosage: 75 mg, 1x/day
Fluticasone Furoate
Dosage: 2 sprays daily
Abilify
Dosage: 15 mg, 2x/day
Vivelle
Dosage: 0.1 mg, unk
Loratadine
Dosage: 10 mg, 1x/day
Robaxin
Dosage: 750 mg, 3x/day
Administration route: Oral
Possible Zestoretic side effects in female
Reported by a physician from United States on 2011-12-19
Patient: female, weighing 89.4 kg (196.7 pounds)
Reactions: Dysarthria, Polymedication, Mental Status Changes, Condition Aggravated, Hypertension, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Abilify
Dosage: 15 mg, 2x/day
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Fluticasone Propionate
Dosage: 2 sprays daily
Vicodin
Dosage: 5/500 prn
Ambien
Dosage: 10 mg, 1x/day
Administration route: Oral
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Lyrica
Dosage: 75 mg, 1x/day
Vivelle
Dosage: 0.1 mg, unk
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Robaxin
Dosage: 750 mg, 3x/day
Administration route: Oral
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Ibuprofen
Dosage: 800 mg, 3x/day
Clonazepam
Dosage: 1 mg, 2x/day
Loratadine
Dosage: 10 mg, 1x/day
Zestoretic
Dosage: 20/12.5 daily
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Lexapro
Dosage: 20 mg, 1x/day
Possible Zestoretic side effects in female
Reported by a physician from United States on 2011-12-16
Patient: female, weighing 89.4 kg (196.7 pounds)
Reactions: Dysarthria, Polymedication, Condition Aggravated, Mental Status Changes, Hypertension, Hypokalaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Lexapro
Dosage: 20 mg, 1x/day
Vivelle
Dosage: 0.1 mg, unk
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded NO Subject Drug
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Loratadine
Dosage: 10 mg, 1x/day
Robaxin
Dosage: unknown
Abilify
Dosage: 15 mg, 2x/day
Ibuprofen
Dosage: 800 mg, 3x/day
Clonazepam
Dosage: 1 mg, 2x/day
Fluticasone
Dosage: 2 sprays daily
Zestoretic
Dosage: 20/12.5 daily
Ambien
Dosage: 10 mg, 1x/day
Administration route: Oral
Lyrica
Dosage: 75 mg, 1x/day
Robaxin
Dosage: 750 mg, 3x/day
Administration route: Oral
Blinded Placebo
Dosage: blinded therapy daily
Administration route: Oral
Indication: Menopausal Symptoms
Start date: 2008-09-09
End date: 2008-11-22
Blinded Desvenlafaxine Succinate Monohydrate
Dosage: blinded therapy daily
Administration route: Oral
Start date: 2008-11-29
End date: 2008-12-24
Vicodin
Dosage: 5/500 prn
Possible Zestoretic side effects in 72 year old female
Reported by a consumer/non-health professional from United States on 2011-11-07
Patient: 72 year old female, weighing 62.1 kg (136.6 pounds)
Reactions: Tinnitus, Ear Haemorrhage, Pain, Deafness, Headache, Cardiac Disorder, Eye Haemorrhage, Overdose, Balance Disorder, Heart Rate Irregular, Tympanic Membrane Perforation, Transient Ischaemic Attack, Bladder Cancer, Renal Disorder, Cerebral Atrophy, Cerebrovascular Accident, Ulcer, Renal Failure, Dysphonia, Visual Impairment, Bladder Disorder, Hypertension
Drug(s) suspected as cause:
Atenolol
Administration route: Oral
Indication: Hypertension
Zestoretic
Dosage: 10/12.5 mg
Administration route: Oral
Indication: Hypertension
Start date: 2002-01-01
End date: 2005-11-23
Other drugs received by patient: Atenolol / Chlorthiadone(mylan); Sulfa; Bactrim
|